Alnylam Pharmaceuticals financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

앨나일램 파머슈티컬스NASDAQ:ALNY · Nasdaq · Healthcare

$219.72-4.96%

2026-10-02 close

Alnylam Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $2.25B. 2024 operating profit was −$177M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy